These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 34180981)

  • 1. Cumulated burden of COVID-19 in Spain from a Bayesian perspective.
    Moriña D; Fernández-Fontelo A; Cabaña A; Arratia A; Ávalos G; Puig P
    Eur J Public Health; 2021 Oct; 31(4):917-920. PubMed ID: 34180981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Economic Impact of the SARS-COV-2 (COVID-19) Pandemic in Spain.
    Pinilla J; Barber P; Vallejo-Torres L; Rodríguez-Mireles S; López-Valcárcel BG; Serra-Majem L
    Int J Environ Res Public Health; 2021 Apr; 18(9):. PubMed ID: 33925185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Main differences between the first and second waves of COVID-19 in Madrid, Spain.
    Soriano V; Ganado-Pinilla P; Sanchez-Santos M; Gómez-Gallego F; Barreiro P; de Mendoza C; Corral O
    Int J Infect Dis; 2021 Apr; 105():374-376. PubMed ID: 33684560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unraveling the COVID-19 hospitalization dynamics in Spain using Bayesian inference.
    Aleta A; Blas-Laína JL; Tirado Anglés G; Moreno Y
    BMC Med Res Methodol; 2023 Jan; 23(1):24. PubMed ID: 36698070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altitude and SARS-CoV-2 Infection in the First Pandemic Wave in Spain.
    Castilla J; Fresán U; Trobajo-Sanmartín C; Guevara M
    Int J Environ Res Public Health; 2021 Mar; 18(5):. PubMed ID: 33806642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimated Covid-19 burden in Spain: ARCH underreported non-stationary time series.
    Moriña D; Fernández-Fontelo A; Cabaña A; Arratia A; Puig P
    BMC Med Res Methodol; 2023 Mar; 23(1):75. PubMed ID: 36977977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Bayesian spatio-temporal analysis of mortality rates in Spain: application to the COVID-19 2020 outbreak.
    Saavedra P; Santana A; Bello L; Pacheco JM; Sanjuán E
    Popul Health Metr; 2021 May; 19(1):27. PubMed ID: 34059063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seroprevalence of SARS-CoV-2 antibodies in over 6000 healthcare workers in Spain.
    Varona JF; Madurga R; Peñalver F; Abarca E; Almirall C; Cruz M; Ramos E; Castellano Vázquez JM
    Int J Epidemiol; 2021 May; 50(2):400-409. PubMed ID: 33434269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibility to Severe Acute Respiratory Syndrome Coronavirus 2 Infection Among Children and Adults: A Seroprevalence Study of Family Households in the Barcelona Metropolitan Region, Spain.
    Brotons P; Launes C; Buetas E; Fumado V; Henares D; de Sevilla MF; Redin A; Fuente-Soro L; Cuadras D; Mele M; Jou C; Millat P; Jordan I; Garcia-Garcia JJ; Bassat Q; Muñoz-Almagro C;
    Clin Infect Dis; 2021 Jun; 72(12):e970-e977. PubMed ID: 33180914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence: Navigating the absence of a gold standard.
    Saeed S; O'Brien SF; Abe K; Yi QL; Rathod B; Wang J; Fazel-Zarandi M; Tuite A; Fisman D; Wood H; Colwill K; Gingras AC; Drews SJ
    PLoS One; 2021; 16(9):e0257743. PubMed ID: 34555095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced surveillance of COVID-19 in Scotland: population-based seroprevalence surveillance for SARS-CoV-2 during the first wave of the epidemic.
    Dickson E; Palmateer NE; Murray J; Robertson C; Waugh C; Wallace LA; Mathie L; Heatlie K; Mavin S; Gousias P; Von Wissman B; Goldberg DJ; McAuley A
    Public Health; 2021 Jan; 190():132-134. PubMed ID: 33453689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-COV-2 Infection and Specific Antibody Detection on Health Care Workers from a Military Hospital in Madrid, Spain.
    Simón Sacristán M; Ybarra de Villavicencio C; Collazos Blanco A; Mayo Montero ME; Ariñez Fernández MDC; Suárez Prieto A; Zamora Cintas MI; Mateo Maestre M
    Curr Microbiol; 2021 Aug; 78(8):2910-2915. PubMed ID: 34156544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seroprevalence of SARS-CoV-2 IgG specific antibodies among healthcare workers in the Northern Metropolitan Area of Barcelona, Spain, after the first pandemic wave.
    Barallat J; Fernández-Rivas G; Quirant-Sánchez B; González V; Doladé M; Martinez-Caceres E; Piña M; Matllo J; Estrada O; Blanco I
    PLoS One; 2020; 15(12):e0244348. PubMed ID: 33370363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19: Estimation of the transmission dynamics in Spain using a stochastic simulator and black-box optimization techniques.
    Matabuena M; Rodríguez-Mier P; García-Meixide C; Leborán V
    Comput Methods Programs Biomed; 2021 Nov; 211():106399. PubMed ID: 34607036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of the COVID-19 pandemic on the care of cancer patients in Spain.
    Amador M; Matias-Guiu X; Sancho-Pardo G; Contreras Martinez J; de la Torre-Montero JC; Peñuelas Saiz A; Garrido P; García-Sanz R; Rodríguez-Lescure Á; Paz-Ares L
    ESMO Open; 2021 Jun; 6(3):100157. PubMed ID: 34015642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood Donations and Transfusions during the COVID-19 Pandemic in Spain: Impact According to Autonomous Communities and Hospitals.
    García-Erce JA; Romón-Alonso Í; Jericó C; Domingo-Morera JM; Arroyo-Rodríguez JL; Sola-Lapeña C; Bueno-Cabrera JL; Juárez-Vela R; Zalba-Marcos S; Abad-Motos A; Gea-Caballero V; Santolalla-Arnedo I; Quintana-Díaz M
    Int J Environ Res Public Health; 2021 Mar; 18(7):. PubMed ID: 33801650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 seroprevalence in Spain.
    Hoffmann C; Wolf E
    Lancet; 2020 Nov; 396(10261):1484. PubMed ID: 33160562
    [No Abstract]   [Full Text] [Related]  

  • 18. SARS-CoV-2 seroprevalence in Spain.
    George TP
    Lancet; 2020 Nov; 396(10261):1484. PubMed ID: 33160560
    [No Abstract]   [Full Text] [Related]  

  • 19. The europe second wave of COVID-19 infection and the Italy "strange" situation.
    Bontempi E
    Environ Res; 2021 Feb; 193():110476. PubMed ID: 33221311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 seroprevalence in Spain - Authors' reply.
    Pollán M; Pérez-Gómez B; Pastor-Barriuso R; Oteo J; Pérez-Olmeda M; Yotti R;
    Lancet; 2020 Nov; 396(10261):1484-1485. PubMed ID: 33160561
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.